3 sources checked · 2 source groups included · 4h ago
Still Watching
New personalised vaccine breakthrough stops cancer returning in trial
Irish Times and India Today describe the same event in different terms.
1 Left2 Center0 Right
Still watching.Optics is waiting for a cleaner match before calling the split.
STILL WATCHING
As of August 20, 2026 at 8:10 AM, this is how Optics News reads the wording differences in this story.
What happenedA new jab extended the length of time patients were cancer free, but it is unclear for how long.
The headline splitThe left frames it as "What is Moderna’s new cancer vaccine and how big a breakthrough is it?". The center frames it as "Moderna cancer vaccine steps closer to clinic use after late-stage trial milestone".
Match confidenceMedium confidence. 3 sources across 2 bias buckets. Useful framing signal — check the source list before sharing.
Same-event confidenceMedium
3 sources across 2 bias buckets agree on the event.
Framing confidenceModerate
64/99 — meaningful wording shift across the spectrum.
WHAT EACH SIDE EMPHASIZED
Left / center-leftWhat is Moderna’s new cancer vaccine and how big a breakthrough is it?
Irish Times · Center-left · News report
CenterNew personalised vaccine breakthrough stops cancer returning in trial
BBC News · Center · News report
Right / center-rightNo matching source in this bucket yet.